{"id":397657,"date":"2020-12-10T13:01:41","date_gmt":"2020-12-10T18:01:41","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397657"},"modified":"2020-12-10T13:01:41","modified_gmt":"2020-12-10T18:01:41","slug":"boston-scientific-corporation-class-action-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-securities-class-action-lawsuit-has-been-filed-in-the-united-states-district-court-for","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/boston-scientific-corporation-class-action-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-securities-class-action-lawsuit-has-been-filed-in-the-united-states-district-court-for\/","title":{"rendered":"BOSTON SCIENTIFIC CORPORATION CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Boston Scientific Corporation"},"content":{"rendered":"

\nLEAD PLAINTIFF DEADLINE IS FEBRUARY 2, 2021
\n<\/h2>\n
\n

NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP<\/a> announces that a federal securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors who purchased or acquired the securities of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) from April 24, 2019 through November 16, 2020 (the “Class Period”).<\/p>\n

\n All <\/strong>
\n i<\/strong>
\n nvestors <\/strong>
\n who<\/strong>
\n purchased<\/strong>
\n shar<\/strong>
\n es<\/strong>
\n of<\/strong>
\n Boston Scientific Corporation and<\/strong>
\n incurred losses <\/strong>
\n a<\/strong>
\n re<\/strong>
\n u<\/strong>
\n rged<\/strong>
\n to contact the firm <\/strong>
\n i<\/strong>
\n mmediately at <\/strong>
\n
\n classmember@whafh.com<\/strong>
\n <\/a>
\n or (800) 575-0735 or (212) 545-4774.<\/strong>
\n You may o<\/strong>
\n btain additional information conc<\/strong>
\n erning the action <\/strong>
\n or <\/strong>
\n
\n join the case<\/strong>
\n <\/a>
\n on our <\/strong>
\n website<\/strong>
\n , <\/strong>
\n
\n www.whafh.com<\/strong>
\n <\/a>
\n
\n .<\/strong>
\n <\/a>\n <\/p>\n

If you have incurred losses in the shares of Boston Scientific Corporation<\/strong>, you<\/strong>may<\/strong>,<\/strong>no<\/strong>later than<\/strong>February<\/strong> 2<\/strong>, <\/strong>2021<\/strong>,<\/strong> request that the Court appoint you lead plaintiff of the proposed class.\u00a0 Please contact Wolf Haldenstein<\/a> to learn more about your rights as an investor in the shares of Boston Scientific Corporation<\/strong>.<\/strong><\/p>\n

\n CLICK HERE TO JOIN CASE<\/a>\n <\/p>\n

The filed complaint alleges that during the Class Period, defendants made false and\/or misleading statements and\/or failed to disclose that:<\/p>\n